Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X

Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta bloc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Iran J Pharm Res
Autores principales: Majidinia, Maryam, Rasmi, Yousef, Khadem Ansari, Mohammad Hassan, Seyed-Mohammadzad, MirHossein, Saboory, Ehsan, Shirpoor, Alireza
Formato: Artigo
Lenguaje:Inglês
Publicado: Shaheed Beheshti University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5149044/
https://ncbi.nlm.nih.gov/pubmed/27980592
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares